Latest News
MJH Associates Acquires Medical Networking, Bolstering Healthcare Offering
Wednesday 07 November 2018

7 November 2018 - US-based health care communications company MJH Associates Inc has acquired Medical Networking, Inc., a privately held company that owns Medstro and MedTech Boston, the firm said.

This acquisition further enhances MJH's position in health care communications with Medstro's software as a service and MedTech Boston's reach into the digital health and medical technology readership, said Michael J. Hennessy Jr., president of MJH Associates Inc.

Founded and run by physician Jennifer Joe, M.D., Medstro is the leading software as a service platform for medicine and health care in three different markets: online communities, online challenges and social content delivery for traditional publishers.

It is used by some of the oldest and most prestigious nonprofit and for-profit organizations, companies and hospital systems, such as the NEJM Group. Unlike its competitors, Medstro's software is highly customizable, with a feature set tailored for the clinical and scientific communities.

Established in 2013, MedTech Boston is a media brand that includes 3 social media handles, an online publication, and a signature annual event.

Because it was one of the first online publications dedicated to covering digital health -- medical technology, sensors, wearables, the connected patient and mobile applications -- it has deep reach into this readership.

This year marked the ever successful fourth annual MedTech Boston 40 Under 40 Healthcare Innovators Awards Program, recognizing the bright up and coming stars in this burgeoning field.

MJH Associates is a health care communications company offering education, research and medical media.

Clients include pharmaceutical, medical device, diagnostic and biotech companies.
Details
Date Published: 07/11/2018
Target: Medical Networking, Inc
Country: USA
Sector: Healthcare
Type: Corporate acquisition
Financing:
Status: Closed
Vendor:
Buyer: MJH Associates Inc
Comment:
Terms of the deal were not disclosed

Options